Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Comparison of cases and controls who did and did not undergo revision surgery

From: Endoscopic sinus surgery outcomes in patients with chronic rhinosinusitis and immunoglobulin deficiencies

 

Revision surgery (Cases) (N = 4)

No revision surgery (Cases) (N = 9)

Revision surgery (Controls) (N = 3)

No Revision surgery (Controls) (N = 23)

Male (n, %)

2 (50)

3 (33)

1 (33)

8 (35)

Age (mean ± SD)

34.8 ± 8.6

48.4 ± 15.9

45.3 ± 20.0

43.4 ± 13.3

Asthma (n, %)

2 (50)

4 (44)

1 (33)

11 (48)

CRSwNP (n, %)

4 (100)

4 (44)

2 (67)

14

CRSsNP (n, %)

0 (0)

5 (56)

1 (33)

9

Preoperative LMS (mean ± SD)

14 ± 2.2

13.7 ± 3.4

13.3 ± 6.1

12.7 ± 2.9

Complete ESSa (%)

4 (100)

7 (78)

3 (100)

22

Limited ESSb (%)

0 (0)

2 (22)

0 (0)

1

  1. SD standard deviation, ESS endoscopic sinus surgery, LMS Lund Mackay score, CRSsNP chronic rhinosinusitis without nasal polyps, CRSwNP chronic rhinosinusitis with nasal polyps
  2. aComplete ESS was defined as maxillary antrostomies, total ethmoidectomies, sphenoidotomies, frontal sinusotomies, and nasal polypectomies if polyps are present
  3. bLimited ESS was defined as any ESS that did not fit the definition of complete ESS